26 27 42 in myofibroblast biology and pathogenesis of silica-induced pulmonary fibrosis. In 43 summary, our findings suggest that performing LC-MS/MS on TGF-β1 stimulated 44 lung fibroblasts can uncover novel molecular targets of activated myofibroblasts in 45 silica-exposed lung. 46 47 48
ABSTRACT:
We performed liquid chromatography-tandem mass spectrometry 28 (LC-MS/MS) on control and TGF-β1-exposed rat lung fibroblasts to identify proteins 29 differentially expressed between cell populations. A total of 1648 proteins were found 30 to be differentially expressed in response to TGF-β1 treatment and 196 proteins were 31 expressed at ≥ 1.2 fold relative to control. Guided by these results, we next 32 determined whether similar changes in protein expression were detectable in the rat 33 lung after chronic exposure to silica dust. Of the five proteins selected for further 34 analysis, we found that levels of all proteins were markedly increased in the 35 silica-exposed rat lung, including the proteins for the very low density lipoprotein 36 receptor (VLDLR) and the transmembrane (type I) heparin sulfate proteoglycan called 37 syndecan 2 (SDC2). Because VLDLR and SDC2 have not, to our knowledge, been 38 previously linked to the pathobiology of silicosis, we next examined whether 39 knockdown of either gene altered responses to TGF-β1 in MRC-5 lung fibroblasts. 40 Interestingly, we found knockdown of either VLDLR or SDC2 dramatically reduced 41 collagen production to TGF-β1, suggesting that both proteins might play a novel role proteins. For each channel, the acquired reporter ion intensities were normalized by 156 the sum of all reporter ion intensities of that channel. Normalized intensities were then 157 used to calculate the relative protein abundance and quantify protein 158 ratios (Nesvizhskii et al., 2003) . Proteins identified from these analyses were further 159 analysed to determine function, ontology and location using the PANTHER 160 classification system (Protein Analysis Through Evolutionary Relationships; 161 http://www.pantherdb.org/) (Mi et al., 2013) . 162 Silicosis model. Male Wistar rats were purchased from Vital River Laboratory Animal 163 Technology Co. Ltd. (SCXY 2009-0004; Beijing, China) and all experiments were 164 performed in accordance with the regulations set by the Committee on the Ethics of 165 North China University of Science and Technology. Silica dust was delivered to rats 166 using a HOPE MED 8050 exposure control apparatus (HOPE Industry and Trade Co. 167 Ltd, Tianjin, China) with the SiO2(s5631, Sigma-Aldrich, St. Louis, MO, USA) 168 concentration maintained at 2,000 mg/m 3 (Liu et al., 2017) . At experimental endpoints, 169 bronchoalveolar lavage was performed with 0.9% saline and whole lung tissues were 170 then snap-frozen in liquid nitrogen. 171 Immunohistochemistry (IHC).Paraffin-embedded tissue sections were used for IHC. 172 Endogenous peroxidases were quenched with 3% H2O2 and antigen retrieval was 173 performed using a high-pressure method with deparaffinised sections. The samples were then incubated with primary antibodies against collagen V(COL V, A1515, identify   205   proteins differentially expressed between control and activated fibroblasts, we   206 performed iTRAQ coupled with LC-MS/MS on rat lung fibroblasts treated with or 207 without TGF-β1 for 24 h. Using scaffold integration, we observed a total of 1648 208 proteins differentially expressed between control and TGF-β1 treated cells. Moreover, 209 196 of these proteins were expressed at ≥ 1.2 fold-change (Tables S1 and S2) and 20 210 proteins exhibited a ≥ 1.5 fold-change (Table 1) relative to control.
RESULTS

Proteomic profile differs between control and TGF-β1 lung fibroblasts.To
211
Bioinformatic analyses of differentially expressed proteins in control and TGF-β1
212 stimulated lung fibroblasts. Proteins whose expression changed most significantly 213 after exposure to TGF-β1 were classified into functional classes using the PANTHER 214 analysis. Gene ontology (GO) analysis classified proteins into three distinct categories 215 entitled: 1) molecular function; 2) biological process; and 3) components of the cell. 216 Among these categories most proteins were belonged to molecular functions group 217 (Table S3) , and the major subgroups within this category included: 1) catalytic 218 activity (40%); 2) protein binding (26%), and 3) structural activity (20%). In the 219 biological processes category (Table S4 ), most proteins belonged to the subgroups: 1) 220 cellular process (26%); 2) metabolic process (22%), or 3) cellular 221 component/biogenesis (10%) subgroup; and proteins within the components of a cell 222 group belonged to 1) cell part (40%); 2) cellular organelle (25%); and 3) 223 macromolecular complexes (18%) ( Table S5) . 224 Within PANTHER, class ontology was also performed (Table S6) , with the largest 225 number of proteins assigned to the following categories:1) nucleic acid binding (18%); 226 2) hydrolase (10%); 3) enzyme modulator and transferase (each 7%); 4) cytoskeletal 227 protein (6%); 5) signalling molecule (6%); and 7) transfer/carrier protein (6%). 228 Pathway analysis showed that all proteins that were differentially expressed in 229 response to TGF-β1fell into one of the following signalling pathways: 1) integrin; 2) 230 angiogenesis; 3) CCKR; 4)conadotropin-releasing hormone receptor; 5) p53; 6) 231 Alzheimer disease-presenilin; 7) blood coagulation; 8) cadherin; 9) cholesterol biosynthesis; 10) FGF or 11) Wntsignalling pathways (Table S7) .
Proteinsincreased in TGF-β1 stimulated lung fibroblasts were also increased in 234 the silica-exposed rat lung. To determine whether in vitro findings were 235 representative of changes in vivo, we next performed IHC and western blot analysis 236 on control and silica-exposed lung tissues for those proteins whose expression 237 changed most significantly (≥1.5 fold increase) in response to TGF-β1 treatment. 238 However, our analysis was limited to proteins in which a commercially available 239 antibody for IHC or WB was available; this included the proteins COLV, COL XI, 240 VCAM1, TM214, VLDLR, and SDC2 for protein identification.
241
As shown in Figure 1A , van Gieson (VG) staining confirmed the ability of our model 242 to induce severe fibrotic responses in the rat lung as demonstrated by an increase in 243 extracellular matrix deposition and the large number of silicotic nodules. Western blot 244 analysis also showed an increase in COLI and α-SMA in whole lung tissues and 245 primary lung fibroblasts after silica exposure ( Figure 1B ). 246 As shown in Figure 2 , Western blot analysis revealed a marked increase in the 247 expression of COL V, COL XI, and VCAM1 in the lungs of silica exposed rats, 248 including whole lung tissues and freshly isolated lung fibroblasts. Moreover, IHC 249 staining of the lung showed the elevated levels of COL V and COL XI was confined 250 mostly to the interstitium of the lung, particularly in areas with evidence of active 251 inflammation and fibrosis. Despite multiple attempts, staining for VCAM1 was 252 detected in either the control or the silica-exposed rat lung, indicating that our 253 antibody could not be used for IHC. 254 In addition to the above proteins, we found that levels of VLDLR and SDC2 were 255 also markedly increased by western blot in whole lung tissues and isolated fibroblasts 256 after silica exposure. (Figure 3 ). Significant increases in VLDLR and SDC2 257 expression were also observed by IHC in the silica-exposed lung.
258
Knockdown of VLDLR or SDC2 reduces collagen deposition in 259 TGF-β1stimulated fibroblasts. Although not entirely surprising that collagen levels 260 COL V and COL XL) and VCAM expression (Agassandian et al., 2015) were 261 increased in fibrotic lung tissues we were intrigued by the observation that levels of 262 VLDLR and SDC2 were also markedly elevated in the lung after silica exposure. 263 Even after an exhaustive search, we were unable to find any reports linking either 264 VLDLR or SDC2 to silicosis in any tissues. Based on this, we speculated whether 265 changes in the expression of VLDLR or SDC2 can influence fibrotic responses to 266 TGFβ1 in lung fibroblasts. To test this, we next performed siRNA knockdown of 267 VLDLR or SDC2 in MRC-5 cells using several different siRNA probes. Because the 268 quantity of gene knockdown varied with different siRNAs we utilized only siRNAs 269 demonstrating the most effective knockdown in our studies; this was siRNA 2 and 3 270 for VLDLR, and siRNA 3 for SDC2 ( Figure 4 ). As shown in Figure 4 , we found that 271 knockdown of VLDLR markedly reduced COL I and α-SMA expression in TGFβ1 272 treated MRC-5 fibroblasts. Moreover, we also found that knockdown of SDC2 273 significantly suppressed COLI expression, although non-significant decreases in 274 α-SMA levels were seen in TGFβ1 treated cells.
DISCUSSION
Biomarker discovery can be accomplished using a variety of proteomic approaches and biological specimens, including urine, serum or lysates from whole organ digests.
However, for research in solid organs, such as the heart, brain, kidney or lung, it is often difficult to obtain sufficient quantities of patient samples for proteomic work.
Moreover, tissue lysates, are composed of a conglomeration of different cell types, such as epithelial cells, smooth muscle cells, fibroblasts, immune cells and endothelialium, making it difficult to uncover novel biological mechanisms in individual cell types. Thus, in vitro models of individual cell populations are often employed to identify novel candidate biomarkers of functional processes in vivo (Paul et al., 2013) .
In this study, we performed iTRAQ-coupled LC-MS/MS analysis on rat lung fibroblasts treated with or without TGF-β1 to identify novel markers of activated myofibroblasts in the silica-exposed lung. From these studies, we identified many proteins differentially expressed and 196 proteins expressed at ≥ 1.2 fold relative to control. Importantly, many of these proteins were novel markers and had not previously been linked to TGF-β1 signalling in the lung, including several whose functional classes have been intimately tied to myofibroblast activation such as integrin and angiogenesis pathways as well as those less clearly associated with myofibroblast biology such as nucleic acid binding, hydrolase activity and transferase activity.
An important finding in this study was the observation that some of the proteins we identified in our proteomics analyses were also differentially expressed in the lung after silica exposure. For example, we found that levels of COL XI and COL V were markedly increased in the silicotic lung, although these findings were not surprising given the fact that collagen production is a well-recognized by product of TGF-β1 signalling (Raglow et al., 2015) . However, we also found that VCAM were significantly increased in the lung after silica exposure. The former findings is also not unexpected given that transcript and protein levels of VCAM are reported to be increased in fibroblastic foci of IPF lungs (Agassandian, et al., 2015) .
Two other proteins found to be differentially expressed in our proteomic analyses were VLDLR and SDC2. We were intrigued by these observations because our review of the literature had not previously associated these proteins with silicosis.
Western blot analysis and IHC confirmed that both proteins were increased in whole lung tissues and isolated fibroblasts from the lungs of silica-exposed rats.
Interestingly, VLDLR expression is known to be increased in the fibrotic caps of atherosclerotic lesions in systemic blood vessels, suggesting it may be involved in more than just lipid trafficking (Eck et al., 2005) . In IPF patient lung tissues, SDC2 was found to be over-expressed in two reports (Chen et al., 2004; Ruiz et al., 2012) .
More importantly, we found that knocking down the expression of either VLDLR or SDC2 effectively reduced collagen production, supporting the notion that these proteins play a role in the pathobiology of pulmonary fibrosis.
In conclusion, iTRAQ coupled LC-MS/MS of TGF-β1-induced fibroblasts can be utilized to identify novel markers of silica-induced lung fibrosis. Future mechanistic studies will be needed to uncover whether individual proteins are simply a marker of disease or play a biological role in the onset or progression of pulmonary fibrosis.
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The authors declare that they have no competing interests. Table S3 . GO analysis of differential proteins performed in PANTHER and classified based on molecular function molecular function Up-regulated proteins Down-regulated proteins catalytic activity (GO:0003824) 37 PDCL3; LYOX; TANC1; GMFB; CGL; FPPS; VATF; PDIA1; PCOC1; PPME1; ARHG6; LYPA2; SERB; TPM2; PDXK; ARSB; ERG1; ORN; EI2BG; RHOA; HIBCH; CK5P3; 2AAB; METK2; GFPT2; DYR; THRB; MAGI3; PAI1; PA24A; CYBP; ARFG1; ADAS; ATIF1; IPP2; GSH0; GNL3 28 KIF1B; SMC1A; THTM; MRCKA; CAV1; BST1; CATL1; AL3A1; CATA; RPN2; CN37; CTHR1; LPP3; DHI1; PSME2; RASA1; COX7C; LPP1; P85A; GLO2; MAGT1; AAK1; BZW2; APOE; MYO1B; HXK1; NT5D2; HMGCL binding (GO:0005488) 24 GMFB; FGF2; CRIP2; SSRA; PCOC1; PAIRB; ARHG6; RL10A; S10AB; SERB; PURB; EI2BG; LRRF1; RHOA; FSTL1; CYR61; OLR1; TCTP; ARFG1; CHSP1; RS13; ATIF1;
RL35A; YKT6 
